Biotechnology Archives | ### STAGING ### RamaOnHealthcare

Pharma / Biotech: Biotechnology

Read recent healthcare news on biotechnology in healthcare. Stay current on trends with our daily newsletter. Also, research insights with our curated search portal.

A biotech startup launches with $38M to develop a cystic fibrosis gene therapy

2022-06-21T20:39:31-04:00

BioPharma Dive June 21, 2022

A biotech startup launches with $38M to develop a cystic fibrosis gene therapy2022-06-21T20:39:31-04:00

ICER’s 2022 “Barriers to Fair Access Assessment” Protocol

2022-06-21T20:38:46-04:00

Healthcare Economist June 21, 2022

ICER’s 2022 “Barriers to Fair Access Assessment” Protocol2022-06-21T20:38:46-04:00

In brief: anticompetitive agreements in the pharmaceutical sector in USA

2022-06-20T17:50:21-04:00

Lexology June 21, 2022

In brief: anticompetitive agreements in the pharmaceutical sector in USA2022-06-20T17:50:21-04:00

Snapshot: anticompetitive unilateral conduct in the pharmaceutical sector in USA

2022-06-20T17:49:16-04:00

Lexology June 21, 2022

Snapshot: anticompetitive unilateral conduct in the pharmaceutical sector in USA2022-06-20T17:49:16-04:00

Mark Cuban’s generic drug prices would save Medicare billions of dollars: Harvard study

2022-06-21T17:28:12-04:00

Becker's Healthcare June 21, 2022

Mark Cuban’s generic drug prices would save Medicare billions of dollars: Harvard study2022-06-21T17:28:12-04:00

$3 Billion in Cancer Drug Waste: Can It Be Salvaged?

2022-06-21T16:31:01-04:00

Medscape June 21, 2022

$3 Billion in Cancer Drug Waste: Can It Be Salvaged?2022-06-21T16:31:01-04:00

Medicare Could Save $3.6B on Generic Drugs If Program Could Match Direct-to-Consumer Pricing

2022-06-20T20:13:28-04:00

HealthLeaders Media June 20, 2022

Medicare Could Save $3.6B on Generic Drugs If Program Could Match Direct-to-Consumer Pricing2022-06-20T20:13:28-04:00

Medicare could save up to $3.6 billion by purchasing generic drugs at Mark Cuban prices

2022-06-20T19:28:56-04:00

Medical Xpress June 20, 2022

Medicare could save up to $3.6 billion by purchasing generic drugs at Mark Cuban prices2022-06-20T19:28:56-04:00

Evaluate’s Orphan Drug Report shows rapid acceleration in the space

2022-06-21T16:55:15-04:00

pharmaphorum June 20, 2022

Evaluate’s Orphan Drug Report shows rapid acceleration in the space2022-06-21T16:55:15-04:00

Cancer Clinical Trials Bounce Back After Pandemic Disruptions

2022-06-20T15:42:47-04:00

Medscape June 20, 2022

Cancer Clinical Trials Bounce Back After Pandemic Disruptions2022-06-20T15:42:47-04:00

Decentralised trials gaining ground in oncology, says report

2022-06-19T19:04:28-04:00

pharmaphorum June 17, 2022

Decentralised trials gaining ground in oncology, says report2022-06-19T19:04:28-04:00

U.S. Supreme Court Unanimously Rules in Favor of Hospitals in 340B Decision

2022-06-20T17:46:31-04:00

Lexology June 17, 2022

U.S. Supreme Court Unanimously Rules in Favor of Hospitals in 340B Decision2022-06-20T17:46:31-04:00

Improving Data Standardization in Neuroscience Research

2022-06-19T11:03:06-04:00

Bio-IT World June 17, 2022

Improving Data Standardization in Neuroscience Research2022-06-19T11:03:06-04:00

Creating Influence and Authority in Value-Based Healthcare

2022-06-19T10:22:02-04:00

Pharmaceutical Executive June 17, 2022

Creating Influence and Authority in Value-Based Healthcare2022-06-19T10:22:02-04:00

Q&A With Paul Ford, co-founder and president, DS9 Capital

2022-06-19T10:20:35-04:00

Pharmaceutical Executive June 17, 2022

Q&A With Paul Ford, co-founder and president, DS9 Capital2022-06-19T10:20:35-04:00

New McKinsey center helps clients build capabilities in cell and gene therapy technology

2022-06-18T21:04:16-04:00

McKinsey June 16, 2022

New McKinsey center helps clients build capabilities in cell and gene therapy technology2022-06-18T21:04:16-04:00

Gene Genies: Inside The Revolutionary Biotech That Can Edit DNA Inside Living Humans

2022-06-16T17:34:48-04:00

Forbes June 16, 2022

Gene Genies: Inside The Revolutionary Biotech That Can Edit DNA Inside Living Humans2022-06-16T17:34:48-04:00

Supreme Court’s 340B Ruling Resonates Throughout Healthcare Industry

2022-06-16T17:03:34-04:00

ICD10monitor June 16, 2022

Supreme Court’s 340B Ruling Resonates Throughout Healthcare Industry2022-06-16T17:03:34-04:00

Supreme Court sides with low-income hospital groups in decision about drug reimbursements

2022-06-15T21:53:47-04:00

MedCity News June 15, 2022

Supreme Court sides with low-income hospital groups in decision about drug reimbursements2022-06-15T21:53:47-04:00

SCOTUS Strikes Down 340B Cuts; Hospitals Whoop

2022-06-15T20:23:21-04:00

HealthLeaders Media June 15, 2022

SCOTUS Strikes Down 340B Cuts; Hospitals Whoop2022-06-15T20:23:21-04:00

Effective Biomedical Public-Private Partnerships Are About Innovation, Not Lower Drug Prices

2022-06-15T19:42:44-04:00

Health Affairs June 15, 2022

Effective Biomedical Public-Private Partnerships Are About Innovation, Not Lower Drug Prices2022-06-15T19:42:44-04:00

Bill & Melinda Gates Foundation Awards Grant to Flywheel

2022-06-18T19:40:44-04:00

HIT Consultant June 15, 2022

Bill & Melinda Gates Foundation Awards Grant to Flywheel2022-06-18T19:40:44-04:00

Supreme Court Decides in Favor of 340B Hospitals Regarding Medicare Reimbursement Methodology

2022-06-19T19:13:13-04:00

Lexology June 15, 2022

Supreme Court Decides in Favor of 340B Hospitals Regarding Medicare Reimbursement Methodology2022-06-19T19:13:13-04:00

US Supreme Court overturns $1.6B 340B payment cut

2022-06-15T17:28:45-04:00

Becker's Healthcare June 15, 2022

US Supreme Court overturns $1.6B 340B payment cut2022-06-15T17:28:45-04:00